Endometrial cancer trial XPORT-EC-042 opens to recruitment
The XPORT-EC-042 study is open to recruitment in Australia, after Border Medical Oncology Research Unit and Peter MacCallum Cancer Centre were activated. The trial is led by Karyopharm Therapeutics (Global Sponsor), in collaboration with ANZGOG, European [...]